eczema
Conditions
Interventions
treatment group:Wubailiazi granules + cetirizine + Disongzhangbo cream
control group:Placebo + cetirizine + Disongzhangbo cream
Sponsors
Shanghai Skin disease Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Age >=18 years old, male or female; 2. Patients with clinical diagnosis of eczema (diagnosis basis: mainly based on clinical diagnosis, refer to the Immunology group of Dermatology and Venereology Branch of Chinese Medical Association "Eczema Diagnosis and Treatment Guide (2011)", Zhao Bian "Chinese Clinical Dermatology (2009)"); 3. Lesions were mild or moderate, according to the investigator's Overall Assessment (IGA) scoring criteria, that is, IGA was 2-3 points. 4. For the first time: newly diagnosed cases or patients taking drugs again after 1 month of drug withdrawal; 5. Volunteer to participate in this experiment and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Systemic eczema, perianal eczema and other special types of eczema; 2. Pregnant or lactating women; 3. Patients with serious primary diseases of cardiovascular, cerebrovascular, liver, kidney and hematopoietic system and mental diseases; 4. Do not follow the doctor's advice, do not cooperate with treatment; 5. Those who are allergic to Wubai Lishi granules.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| effective rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| IGA;EASI;Visual Analogue Scale VAS;dermatology life quality index DLQI; | — |
Countries
China
Contacts
Public ContactChen Zhongjian
Shanghai Skin disease Hospital
Outcome results
None listed